Basilea reports on commercial progress of antifungal Cresemba® in Europe
Cresemba launched by Pfizer in Spain and is now commercially available in all Top-5 EU markets Marketing authorization received for Switzerland Basel, Switzerland, November 2, 2017 - Basilea Pharmaceutica Ltd. (SIX: BSLN) announced today that its licensing …